Navigation Links
U.S. Officials Take Aim at Questionable STD Products
Date:5/3/2011

TUESDAY, May 3 (HealthDay News) -- The U.S. Food and Drug Administration and the U.S. Federal Trade Commission are cracking down on manufacturers of over-the-counter products that claim to treat, cure or prevent sexually transmitted diseases.

The agencies jointly sent letters to companies including Medavir, Herpaflor, Viruxo, C-Cure and Never An Outbreak, warning that their products are unproven and violate federal law, the FDA said in a news release issued Tuesday.

"These products are dangerous because they are targeted to patients with serious conditions, where treatment options proven to be safe and effective are available," Deborah M. Autor, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research, said in the release.

Chlamydia, genital warts, herpes, HIV and AIDS are among the diseases that the products -- sold online and through retail outlets -- claim to treat. However, the only FDA-approved medications available to treat these conditions require a prescription and supervision of a health-care professional, the agency said.

Because the products have not been evaluated for safety and effectiveness, people who buy them may not get needed treatment and could then infect their sexual partners, Autor said.

The items are considered drug products under the Federal Food, Drug, and Cosmetic Act because they are sold to treat disease, and they violate interstate commerce law if they lack an FDA-approved new drug application, the FDA explained. Further, under the Federal Trade Commission Act it is illegal to make unsubstantiated treatment claims, regulators said.

"These companies are on notice that advertising health benefits that are not supported by rigorous scientific evidence violates the FTC Act," said David Vladeck, director of the FTC's Bureau of Consumer Protection. Health scams that endanger public health will not be tolerated, he added.

The letters are the first step in removing the unproven products from the market. The companies have 15 days to inform the FDA of measures they're taking to correct the alleged violations or face possible legal action.

More information

The U.S. National Library of Medicine has more about sexually transmitted diseases.

-- HealthDay staff

SOURCE: U.S. Food and Drug Administration, news release, May 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Online Tool Created to Contact Vatican Officials: Why Are American Bishops Allowed to Defy the Popes Words Concerning Child Killing and the Eucharist?
2. Officials See Uptick in H1N1 Swine Flu Cases
3. Infant Sleep Positioners Dangerous, U.S. Health Officials Warn
4. U.S. Officials Recommend Reduced Fluoride Levels in Water
5. LearnSomething Brings Phil Keough On Board to Spearhead Retail Products and Services
6. Health & Sports: Former NBA Star John Salley Endorses STEMTech Stem Cell Nutrition Products
7. For a Healthier, Cleaner Fitness Regimen - Venture Products Shock Athletic(TM) Mats and Interlocking Flooring
8. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
9. Summit VetPharm Enters Agreement With MWI Veterinary Supply to Distribute Vectra(R) Products
10. GNC Announces Entry to Chinas Nutritional Products in Partnership with Bright Food
11. First Coast Service Options (FCSO) Expands Use of Burgess Products
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Officials Take Aim at Questionable STD Products 
(Date:2/20/2017)... ... 20, 2017 , ... Researchers at the University of Pittsburgh School of Medicine ... that may predict response to a particular class of drugs, not just in patients ... The new findings were published in Proceedings of the National Academy of Science. , ...
(Date:2/20/2017)... ... 2017 , ... The StayWell Company and VUCA Health ... health risks, foster behavior change and improve health literacy among patients. VUCA Health, which ... demonstration of its video capability at StayWell booth 3443 during HiMSS. , The ...
(Date:2/20/2017)... ... February 20, 2017 , ... Sensogram Technologies Inc., the world ... visit this week at HIMSS 2017 Conference & Exhibition. The event brings more ... will be featured in the conference’s Connected Health Experience section, an area specifically ...
(Date:2/20/2017)... ... ... a Population Health Software Company, is pleased to announce a move to a larger office ... the size of the previous location while bringing life back to a medical practice building ... are excited to expand our footprint to better serve our growing client base. We ...
(Date:2/20/2017)... ... February 20, 2017 , ... Johns Hopkins All Children's Hospital ... A topping out ceremony on Friday marked the halfway point of construction and lifting ... in Fall 2018, will serve as a center for innovation aimed at finding new ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... Feb. 19, 2017   AC Group Inc. , ... ranking of vendors in the PMS/EHR healthcare marketplace, will ... system requirements to succeed in this ecosystem at HIMSS,17. ... together information obtained from over 200 ACOs, compared and ... and services companies that are providing different pieces of ...
(Date:2/19/2017)... ORLANDO, Fla. , Feb. 18, 2017 /PRNewswire/ ... announced that positive Phase 1 clinical data for Nektar,s ... carcinoma (RCC) were presented at ASCO GU 2017.  NKTR-214 ... cancer-fighting T cells and Natural Killer (NK) cell abundance ... PD-1 on these immune cells.  The results were presented ...
(Date:2/18/2017)... , Feb. 17, 2017  Pharmaceutical companies have long ... products either in development or already on the market.   ... the pharma industry to alter how it manages advisory board ... leader Best Practices, LLC conducted a new study focused on ... ...
Breaking Medicine Technology: